Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gem-disubstituted piperidine melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

Gem-disubstituted piperidine melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

US Patent 12492181 · Granted Dec 9, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof2025
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof2025
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof2025
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof2025
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof2025
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof2025
Ultrasound image processing apparatus, method, program and system2025
Spirocyclic piperidine melanocortin subtype-2 receptor (MC2R) antagonists and us2025
Spirocyclic piperidine melanocortin subtype-2 receptor (MC2R) antagonists and us2025
Spirocyclic piperidine melanocortin subtype-2 receptor (MC2R) antagonists and us2025
Max and MXene using vanadium carbide and method for manufacturing same2025
Metamaterial structure, metamaterial-type transparent heater, and radar apparatu2025